PREDICTIVE ONCOLOGY INC (POAI) Stock Overview
USA - NASDAQ:POAI - US74039M3097 - Common Stock
POAI Key Statistics, Chart & Performance
The current stock price of POAI is 11 USD. In the past month the price decreased by -25.72%. In the past year, price increased by 8.31%.
POAI Latest News, Press Relases and Analysis
POAI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.58 | 222.13B | ||
| ISRG | INTUITIVE SURGICAL INC | 53.99 | 155.80B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.55 | 144.89B | ||
| SYK | STRYKER CORP | 28.74 | 141.17B | ||
| MDT | MEDTRONIC PLC | 17.19 | 121.91B | ||
| BDX | BECTON DICKINSON AND CO | 12.98 | 53.10B | ||
| IDXX | IDEXX LABORATORIES INC | 53.07 | 50.99B | ||
| EW | EDWARDS LIFESCIENCES CORP | 28.27 | 42.65B | ||
| RMD | RESMED INC | 28.27 | 39.53B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.75 | 33.50B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.86 | 27.28B | ||
| DXCM | DEXCOM INC | 39.02 | 26.01B |
Related stock screener links
About POAI
Company Profile
Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal, and associated products. The company is headquartered in Pittsburgh, Pennsylvania and currently employs 23 full-time employees. The company went IPO on 2009-12-18. The Company’s scientifically validated AI platform, PEDAL, is able to predict with 92% accuracy when a tumor sample responds to a certain drug compound, allowing for a more informed selection of drug/tumor type combinations for subsequent in-vitro testing. Through AI, it uses its proprietary biobank of 150,000+ cancer tumor samples, categorized by patient type, against drug compounds to help the drug discovery process and increase the probability of drug development. The firm offers a suite of solutions for oncology drug development from early discovery to clinical trials.
Company Info
PREDICTIVE ONCOLOGY INC
91 43Rd Street, Suite 110
Pittsburgh PENNSYLVANIA 55121 US
CEO: Carl Schwartz
Employees: 23
Phone: 14124321500
PREDICTIVE ONCOLOGY INC / POAI FAQ
What is the stock price of PREDICTIVE ONCOLOGY INC today?
The current stock price of POAI is 11 USD. The price decreased by -19.12% in the last trading session.
What is the ticker symbol for PREDICTIVE ONCOLOGY INC stock?
The exchange symbol of PREDICTIVE ONCOLOGY INC is POAI and it is listed on the Nasdaq exchange.
On which exchange is POAI stock listed?
POAI stock is listed on the Nasdaq exchange.
What is PREDICTIVE ONCOLOGY INC worth?
PREDICTIVE ONCOLOGY INC (POAI) has a market capitalization of 8.36M USD. This makes POAI a Nano Cap stock.
How many employees does PREDICTIVE ONCOLOGY INC have?
PREDICTIVE ONCOLOGY INC (POAI) currently has 23 employees.
What are the support and resistance levels for PREDICTIVE ONCOLOGY INC (POAI) stock?
PREDICTIVE ONCOLOGY INC (POAI) has a resistance level at 13.39. Check the full technical report for a detailed analysis of POAI support and resistance levels.
Is PREDICTIVE ONCOLOGY INC (POAI) expected to grow?
The Revenue of PREDICTIVE ONCOLOGY INC (POAI) is expected to grow by 569.48% in the next year. Check the estimates tab for more information on the POAI EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy PREDICTIVE ONCOLOGY INC (POAI) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of POAI, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of POAI, evaluating the profitability, health, valuation and growth aspects
- PREDICTIVE ONCOLOGY INC (POAI) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- PREDICTIVE ONCOLOGY INC (POAI) Sales and EPS estimates to see what analysts future expectations are.
- PREDICTIVE ONCOLOGY INC (POAI) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- PREDICTIVE ONCOLOGY INC (POAI) Insider and Institutional Ownership to learn about the owners and their transactions.
- PREDICTIVE ONCOLOGY INC (POAI) Stock Chart to make your own analysis
- PREDICTIVE ONCOLOGY INC (POAI) Latest news and press-releases to stay up to date.
Does PREDICTIVE ONCOLOGY INC (POAI) stock pay dividends?
POAI does not pay a dividend.
When does PREDICTIVE ONCOLOGY INC (POAI) report earnings?
PREDICTIVE ONCOLOGY INC (POAI) will report earnings on 2025-11-10.
What is the Price/Earnings (PE) ratio of PREDICTIVE ONCOLOGY INC (POAI)?
PREDICTIVE ONCOLOGY INC (POAI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-20.64).
POAI Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to POAI. When comparing the yearly performance of all stocks, POAI turns out to be only a medium performer in the overall market: it outperformed 43.15% of all stocks.
POAI Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to POAI. Both the profitability and financial health of POAI have multiple concerns.
POAI Financial Highlights
Over the last trailing twelve months POAI reported a non-GAAP Earnings per Share(EPS) of -20.64. The EPS increased by 59.02% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -284.62% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
POAI Forecast & Estimates
For the next year, analysts expect an EPS growth of 93.75% and a revenue growth 569.48% for POAI